Literature DB >> 22440828

A heat-stable cytotoxic factor produced by Achromobacter xylosoxidans isolated from Brazilian patients with CF is associated with in vitro increased proinflammatory cytokines.

Rebeca P Mantovani1, Carlos E Levy, Tomomasa Yano.   

Abstract

BACKGROUND: Recently, Achromobacter xylosoxidans has been related to chronic lung diseases in patients suffering from cystic fibrosis (CF), but its involvement has not been elucidated. Some virulence properties of A. xylosoxidans isolated from Brazilian patients with CF were revealed in this work.
METHODS: This study examined the production of a cytotoxic factor of A. xylosoxidans capable of stimulating the secretion of inflammatory cytokines (IL-6 and IL-8) from lung mucoepidermoid carcinoma cells (NCI-H292). The cytokines were measured using enzyme-linked immunosorbent (ELISA) assays. To investigate whether the cytotoxic factors may be endotoxins, they were treated with polymyxin B.
RESULTS: The culture supernatants of all A. xylosoxidans produced a heat stable, active cytotoxin in NCI-H292 cells capable of leading to intracellular vacuoles and subsequent cell contact loss, chromatin condensation, a picnotic nucleus and cell death. There was a higher concentration of proinflammatory cytokines in the NCI-H292 cells after 24 h of incubation, with the fraction greater than 50 kDa from the culture supernatant. The cytotoxin activity remained even after treatment with polymyxin B, which suggested that the release of IL-6 and IL-8 was not stimulated by lipopolysaccharide (LPS).
CONCLUSION: The cytotoxic factor produced by A. xylosoxidans may represent an important virulence factor, which when associated with CF chronic lung inflammation, may cause tissue damage and decline of lung function.
Copyright © 2012 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22440828     DOI: 10.1016/j.jcf.2012.02.002

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  12 in total

1.  Achromobacter xylosoxidans Cellular Pathology Is Correlated with Activation of a Type III Secretion System.

Authors:  Adam M Pickrum; Orlando DeLeon; Aaron Dirck; Maxx H Tessmer; Molly O Riegert; Julie A Biller; Nathan A Ledeboer; John R Kirby; Dara W Frank
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

2.  Innate aminoglycoside resistance of Achromobacter xylosoxidans is due to AxyXY-OprZ, an RND-type multidrug efflux pump.

Authors:  Julien Bador; Lucie Amoureux; Emmanuel Blanc; Catherine Neuwirth
Journal:  Antimicrob Agents Chemother       Date:  2012-10-22       Impact factor: 5.191

Review 3.  Achromobacter xylosoxidans and Stenotrophomonas maltophilia: Emerging Pathogens Well-Armed for Life in the Cystic Fibrosis Patients' Lung.

Authors:  Quentin Menetrey; Pauline Sorlin; Estelle Jumas-Bilak; Raphaël Chiron; Chloé Dupont; Hélène Marchandin
Journal:  Genes (Basel)       Date:  2021-04-21       Impact factor: 4.096

4.  Clinical impact of Achromobacter xylosoxidans colonization/infection in patients with cystic fibrosis.

Authors:  M C Firmida; R H V Pereira; E A S R Silva; E A Marques; A J Lopes
Journal:  Braz J Med Biol Res       Date:  2016-02-23       Impact factor: 2.590

Review 5.  Bacterial infections in patients with primary ciliary dyskinesia: Comparison with cystic fibrosis.

Authors:  Christiaan Dm Wijers; James F Chmiel; Benjamin M Gaston
Journal:  Chron Respir Dis       Date:  2017-03-06       Impact factor: 2.444

6.  Characterization of the Achromobacter xylosoxidans Type VI Secretion System and Its Implication in Cystic Fibrosis.

Authors:  Mélanie Le Goff; Manon Vastel; Régine Lebrun; Pascal Mansuelle; Ava Diarra; Teddy Grandjean; Pauline Triponney; Geneviève Imbert; Philippe Gosset; Rodrigue Dessein; Fabien Garnier; Eric Durand
Journal:  Front Cell Infect Microbiol       Date:  2022-06-16       Impact factor: 6.073

7.  Isolation and molecular characterisation of Achromobacter phage phiAxp-3, an N4-like bacteriophage.

Authors:  Yanyan Ma; Erna Li; Zhizhen Qi; Huan Li; Xiao Wei; Weishi Lin; Ruixiang Zhao; Aimin Jiang; Huiying Yang; Zhe Yin; Jing Yuan; Xiangna Zhao
Journal:  Sci Rep       Date:  2016-04-20       Impact factor: 4.379

8.  Leukotriene B4 is essential for lung host defence and alpha-defensin-1 production during Achromobacter xylosoxidans infection.

Authors:  Morgana K B Prado; Gisele A Locachevic; Karina F Zoccal; Francisco W G Paula-Silva; Caroline Fontanari; Joseane C Ferreira; Priscilla A T Pereira; Luiz G Gardinassi; Simone G Ramos; Carlos A Sorgi; Ana Lúcia C Darini; Lúcia H Faccioli
Journal:  Sci Rep       Date:  2017-12-15       Impact factor: 4.379

9.  Bacterial Interference With Lactate Dehydrogenase Assay Leads to an Underestimation of Cytotoxicity.

Authors:  Sara Van den Bossche; Eva Vandeplassche; Lisa Ostyn; Tom Coenye; Aurélie Crabbé
Journal:  Front Cell Infect Microbiol       Date:  2020-09-15       Impact factor: 5.293

10.  Genomic characterization of Achromobacter species isolates from chronic and occasional lung infection in cystic fibrosis patients.

Authors:  Laura Veschetti; Angela Sandri; Cristina Patuzzo; Paola Melotti; Giovanni Malerba; Maria M Lleo
Journal:  Microb Genom       Date:  2021-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.